研究方向：抗结核天然免疫机制

　　课题、成果和团队：承担国自然青年基金1项、省部级课题3项、局级课题4项，入选北京市科技新星计划和通州区科技创新人才，荣获华夏医学科技奖二等奖、北京医学科技奖一等奖和首都医科大学科技进步二等奖，获批专利4项，近五年发表SCI文章29篇，累计影响因子138，在结核病精准诊断和天然免疫机制等方面取得了丰富成果。

　　代表作：1.Shanshan Li; Yaoju Tan; Yufeng Deng; Guanghong Bai; Mingxiang Huang; Yuanyuan Shang; Yufeng Wang; Zhongtan Xue; Xuxia Zhang; Wei Wang; Junhua Pan; Yu Pang ; The emerging threat of fluroquinolone-, bedaquiline-, and linezolid-resistant Mycobacterium tuberculosis in China: Observations on surveillance data, Journal of Infection and Public Health, 2024, 171.: 137-142.

　　2. Haoran Li; Ren Weicong; Qingtao Liang; Xuxia Zhang; Qiang Li; Yuanyuan Shang; Liping Ma; Shanshan Li; Yu Pang ; A novel chemokine biomarker to distinguish active tuberculosis from latent tuberculosis: a cohort study, QJM: An International Journal of Medicine, 2023, 116(12.: 1002-1009.

　　3.Yunfeng Deng#, Zichun Ma#, Biyi Su#, Guanghong Bai#, Jianhua Pan#, Quan Wang#, Long Cai#, Yanhua Song#, Yuanyuan Shang, Pinyun Ma, Jing Li, Qianxuan Zhou, Gulibike Mulati, Dapeng Fan, Shanshan Li*, Yaoju Tan*, Yu Pang*. Accuracy of the InnowaveDX MTB/RIF test for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre study. Emerg Microbes Infect. 2023, 121.:2151382.